药物对比
Linagliptin vs Chlorpropamide
Linagliptin 与 Chlorpropamide 治疗2型糖尿病：DPP-4抑制剂与磺脲类。比较疗效、低血糖风险、体重增加，以及哪种可能更可取。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when patients or clinicians evaluate switching from an older first-generation sulfonylurea to a modern DPP-4 inhibitor for type 2 diabetes.
结论
Linagliptin generally provides a more favorable benefit-risk profile than Chlorpropamide for most adults with type 2 diabetes, though individual factors must guide the final choice.
全部药物对比